INS and early-onset autosomal dominant Alzheimer disease: Given the notion that chronic peripheral hyperinsulinemia instigates the downregulation of insulin receptors within the blood–brain barrier, culminating in a concomitant reduction in insulin transport to the brain22, it is plausible to posit that Alzheimer’s disease patients may experience diminished cerebral insulin levels in the presence of peripheral hyperinsulinemia23.